| Date Filed | Type | Description |
| 10/06/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Paid exercise price by delivering 19,993 shares
@ $0.44, valued at
$8.8k
|
|
| 07/06/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Paid exercise price by delivering 19,993 shares
@ $0.914, valued at
$18.3k
|
|
| 04/05/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Paid exercise price by delivering 19,993 shares
@ $1, valued at
$20k
|
|
| 01/06/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Paid exercise price by delivering 23,484 shares
@ $0.85, valued at
$20k
|
|
| 11/22/2022 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Bought 100,000 shares
@ $0.5496, valued at
$55k
|
|
| 10/06/2022 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Granted 263,492 shares
@ $0 |
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Granted 4,000,000 options to buy
@ $0.86, valued at
$3.4M
|
|
| 02/14/2022 |
3
| Camardo Daniel A. (CEO) has filed a Form 3 on ATHERSYS, INC / NEW |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2020 |
4
| Camardo Daniel A. (EVP and President, U.S.) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 3,500 shares
@ $76.7609, valued at
$268.7k
|
|
| 10/22/2020 |
4
| Camardo Daniel A. (EVP and President, U.S.) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Granted 10,000 shares
@ $0
Paid exercise price by delivering 4,460 shares
@ $80.42, valued at
$358.7k
Exercised 10,000 restricted stock units
@ $0 |
|